Cargando…
Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease
Lin28 RNA-binding proteins are stem-cell factors that play key roles in development. Lin28 suppresses the biogenesis of let-7 microRNAs and regulates mRNA translation. Notably, let-7 inhibits Lin28, establishing a double-negative feedback loop. The Lin28/let-7 axis resides at the interface of metabo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792516/ https://www.ncbi.nlm.nih.gov/pubmed/36572670 http://dx.doi.org/10.1038/s41467-022-35481-1 |
_version_ | 1784859652013424640 |
---|---|
author | Lekka, Evangelia Kokanovic, Aleksandra Mosole, Simone Civenni, Gianluca Schmidli, Sandro Laski, Artur Ghidini, Alice Iyer, Pavithra Berk, Christian Behera, Alok Catapano, Carlo V. Hall, Jonathan |
author_facet | Lekka, Evangelia Kokanovic, Aleksandra Mosole, Simone Civenni, Gianluca Schmidli, Sandro Laski, Artur Ghidini, Alice Iyer, Pavithra Berk, Christian Behera, Alok Catapano, Carlo V. Hall, Jonathan |
author_sort | Lekka, Evangelia |
collection | PubMed |
description | Lin28 RNA-binding proteins are stem-cell factors that play key roles in development. Lin28 suppresses the biogenesis of let-7 microRNAs and regulates mRNA translation. Notably, let-7 inhibits Lin28, establishing a double-negative feedback loop. The Lin28/let-7 axis resides at the interface of metabolic reprogramming and oncogenesis and is therefore a potential target for several diseases. In this study, we use compound-C1632, a drug-like Lin28 inhibitor, and show that the Lin28/let-7 axis regulates the balance between ketogenesis and lipogenesis in liver cells. Hence, Lin28 inhibition activates synthesis and secretion of ketone bodies whilst suppressing lipogenesis. This occurs at least partly via let-7-mediated inhibition of nuclear receptor co-repressor 1, which releases ketogenesis gene expression mediated by peroxisome proliferator-activated receptor-alpha. In this way, small-molecule Lin28 inhibition protects against lipid accumulation in multiple cellular and male mouse models of hepatic steatosis. Overall, this study highlights Lin28 inhibitors as candidates for the treatment of hepatic disorders of abnormal lipid deposition. |
format | Online Article Text |
id | pubmed-9792516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97925162022-12-28 Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease Lekka, Evangelia Kokanovic, Aleksandra Mosole, Simone Civenni, Gianluca Schmidli, Sandro Laski, Artur Ghidini, Alice Iyer, Pavithra Berk, Christian Behera, Alok Catapano, Carlo V. Hall, Jonathan Nat Commun Article Lin28 RNA-binding proteins are stem-cell factors that play key roles in development. Lin28 suppresses the biogenesis of let-7 microRNAs and regulates mRNA translation. Notably, let-7 inhibits Lin28, establishing a double-negative feedback loop. The Lin28/let-7 axis resides at the interface of metabolic reprogramming and oncogenesis and is therefore a potential target for several diseases. In this study, we use compound-C1632, a drug-like Lin28 inhibitor, and show that the Lin28/let-7 axis regulates the balance between ketogenesis and lipogenesis in liver cells. Hence, Lin28 inhibition activates synthesis and secretion of ketone bodies whilst suppressing lipogenesis. This occurs at least partly via let-7-mediated inhibition of nuclear receptor co-repressor 1, which releases ketogenesis gene expression mediated by peroxisome proliferator-activated receptor-alpha. In this way, small-molecule Lin28 inhibition protects against lipid accumulation in multiple cellular and male mouse models of hepatic steatosis. Overall, this study highlights Lin28 inhibitors as candidates for the treatment of hepatic disorders of abnormal lipid deposition. Nature Publishing Group UK 2022-12-26 /pmc/articles/PMC9792516/ /pubmed/36572670 http://dx.doi.org/10.1038/s41467-022-35481-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lekka, Evangelia Kokanovic, Aleksandra Mosole, Simone Civenni, Gianluca Schmidli, Sandro Laski, Artur Ghidini, Alice Iyer, Pavithra Berk, Christian Behera, Alok Catapano, Carlo V. Hall, Jonathan Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title | Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title_full | Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title_fullStr | Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title_full_unstemmed | Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title_short | Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
title_sort | pharmacological inhibition of lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792516/ https://www.ncbi.nlm.nih.gov/pubmed/36572670 http://dx.doi.org/10.1038/s41467-022-35481-1 |
work_keys_str_mv | AT lekkaevangelia pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT kokanovicaleksandra pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT mosolesimone pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT civennigianluca pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT schmidlisandro pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT laskiartur pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT ghidinialice pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT iyerpavithra pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT berkchristian pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT beheraalok pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT catapanocarlov pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease AT halljonathan pharmacologicalinhibitionoflin28promotesketogenesisandrestoreslipidhomeostasisinmodelsofnonalcoholicfattyliverdisease |